Get the app!
Back to Trades

Dexter Susan

DirectorCIK 0001806764

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025

Dexter Susan, Director, has filed 2 SEC reports (2025), all concentrated in Sonnet BioTherapeutics Holdings, Inc. (SONN), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Dec 3SONN
Sonnet BioTherapeutics Holdings, Inc.
Dexter SusanDirectorDisposed$0
Jul 15SONN
Sonnet BioTherapeutics Holdings, Inc.
Dexter SusanChief Technical OfficerGrant$0

2 filings